← FDA Drug Approvals (Drugs@FDA)

SYMBRAVO

NDA · New Drug Application · Sponsor: AXSOME · Approved 2025-01-30

Drug application

FDA Application #

NDA215431

Application type

New Drug Application

Brand name

SYMBRAVO

Generic name

MELOXICAM, RIZATRIPTAN

Active ingredients

MELOXICAM; RIZATRIPTAN BENZOATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

AXSOME

Manufacturer

Axsome Therapeutics, Inc.

First approval

2025-01-30

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown